Chemomab Therapeutics
CMMB----
Chemomab Therapeutics (CMMB)
Chemomab Therapeutics Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of therapeutics for the treatment of fibrotic and i...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
Chemomab Therapeutics Analyst Rating
View MoreForecast & Rating
Jul 13, 2026Price forecast
$5.00257.14%
Forecast & RatingBuy
1analysts
- Strong buy0.00%
- Buy100.00%
- Hold0.00%
- Sell0.00%
- Strong sell0.00%
News
- rttnews · Jul 10 at 11:15 AM
Weekly Buzz: JNJ, VERA Get FDA Nod; VRTX Snaps Up CRNX; MSLE Aces DMD Trial; IONS Misses Key Goal
- benzinga_article · Jul 8 at 12:05 PM
12 Health Care Stocks Moving In Wednesday's Intraday Session
- Price Alert · Jul 8 at 09:42 AM
U.S. stock market midday update: Chemomab down 22.45%, merger secures $30 million in financing
- Quartr · Jul 8 at 07:17 AM
Chemomab Therapeutics: Merger creates an AI-powered precision medicine leader advancing nebokitug for RA with $30M funding
- StockTitan · Jul 7 at 10:35 PM
Chemomab Therapeutics and Precision Medicine Pioneer Scipher Medicine Announce Merger Agreement to Advance Nebokitug in an AI-Powered Phase 2 Trial in Rheumatoid Arthritis | CMMB Stock News
- rttnews · Jul 3 at 12:19 AM
Top Biotech Gainers: PPCB Launches Share Buyback, VRXA Partners With ATUM, SLS On Watch
